3 completed, 3 recruiting, 1 withdrawn. 2 Phase 3, 1 Early Phase 1, 1 Not applicable, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 1, Withdrawn 1 |
| Early Phase 1 | 1 | Recruiting 1 |
| Not applicable | 1 | Completed 1 |
| Phase 2 | 1 | Completed 1 |
Follow Calcific Uremic Arteriolopathy: new trials by email Literature Review of Calcific Uremic Arteriolopathy trials Research Report on Calcific Uremic Arteriolopathy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Calciphylaxis in Patients With Chronic Kidney Disease - A Study of the Danish Calciphylaxis Research Initiative (DanCaRI) Calciphylaxis, Calcific Uremic Arteriolopathy | Recruiting | Odense University Hospital | 860 | 2026-04-01 | 2026-04-06 | |
| Phase 3 Study of SNF472 for Calciphylaxis Experimental: SNF472, Placebo Comparator: Placebo, Experimatenl SNF472 (Open-label) - Calciphylaxis, Calcific Uremic Arteriolopathy | Phase 3 | Completed | Sanifit Therapeutics S. A. | 71 | 2020-02-12 | 2024-02-20 |
| Human Amniotic-Derived Mesenchymal Stem Cell Therapy for Calciphylaxis Human amniotic-derived mesenchymal stem cells - Chronic Kidney Diseases, Calciphylaxis | Early Phase 1 | Recruiting | The First Affiliated Hospital with Nanjing Medical University | 9 | 2018-09-17 | 2026-03-04 |
| Partners Calciphylaxis Biobank Calciphylaxis, Calcific Uremic Arteriolopathy | Recruiting | Massachusetts General Hospital | 300 | 2017-01-01 | 2026-09-14 | |
| Phase 2 Study With SNF472 in Calciphylaxis Patients SNF472 - Calciphylaxis, Calcific Uremic Arteriolopathy | Phase 2 | Completed | Sanifit Therapeutics S. A. | 14 | 2016-05-01 | 2019-08-28 |
| Evaluation of Vitamin K Supplementation for Calcific Uremic Arteriolopathy Vitamin K, Placebo - Calciphylaxis, Calcific Uremic Arteriolopathy | Not applicable | Completed | Massachusetts General Hospital | 26 | 2015-03-01 | 2019-09-17 |
| Double-blind Trial of Sodium Thiosulfate for the Treatment of Pain Associated With Calcific Uremic Arteriolopathy Sodium thiosulfate, Placebo - Calciphylaxis, Calcific Uremic Arteriolopathy | Phase 3 | Withdrawn | American Regent, Inc. | 2015-01-30 | 2025-05-07 |
Calciphylaxis (7) · Kidney Failure, Chronic (5) · Renal Insufficiency, Chronic (3) · Rare Diseases (2) · Calcinosis (1) · Calcium Metabolism Disorders (1) · Metabolic Diseases (1) · Wounds and Injuries (1)
Nutritional and Metabolic Diseases (7) · Calcinosis (6) · Calcium Metabolism Disorders (6) · Chronic Disease (6) · Disease Attributes (6) · Female Urogenital Diseases (6) · Female Urogenital Diseases and Pregnancy Complications (6) · Kidney Diseases (6) · Male Urogenital Diseases (6) · Metabolic Diseases (6) · Pathologic Processes (6) · Pathological Conditions, Signs and Symptoms (6) · Renal Insufficiency (6) · Urogenital Diseases (6) · Urologic Diseases (6)
SNF472 (1) · Sodium Chloride (1) · Vitamin K (1) · sodium thiosulfate (1)
Massachusetts General Hospital (2) · Sanifit Therapeutics S. A. (2) · American Regent, Inc. (1) · Odense University Hospital (1) · The First Affiliated Hospital with Nanjing Medical University (1)
United States (5) · United Kingdom (2) · Belgium (1) · China (1) · Denmark (1) · Germany (1) · Poland (1) · Spain (1)
Alex Gold, MD (1) · Alexandra Scholze, Dr.med, PhD (1) · Jiayin Liu, Professor (1) · Lianju Qin (1) · Linda Mundy, MD, PhD (1) · Ningning Wang, Professor (1) · Sagar Nigwekar, MD, MMSc (1) · Sagar U Nigwekar, MD, MMSc (1) · Subagini Nagarajah, PhD (1) · Vincent Brandenburg (1)
PMID 39186385, PMID 35142858, PMID 35412950, PMID 36712824, PMID 39234636, PMID 39252867, PMID 40097288, PMID 40518559, PMID 41472909